Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Jak-2 inhibitor indicated for control of allergic inflammation

March 24, 1998

Clinical efficacy demonstrated for rhuMAb-E25 in asthma

March 24, 1998

P-gp as a complicating factor in childhood rheumatic diseases

March 24, 1998

Mochida describes new antiasthma agent with novel profile

March 23, 1998

Potential new indication for zafirlukast in the treatment of urticaria

March 23, 1998

L-0066: a novel inhibitor of PDE IV and mediator release in vitro

March 23, 1998

Synergistic effects of montelukast and loratadine in allergic patients

March 23, 1998

Antiasthma effects of first-generation Primatized anti-CD4 MAb studied in patients

March 23, 1998

Nuvance stabilizes lung function in asthmatic patients

March 17, 1998

Cel-Sci on the way to developing a worldwide AIDS vaccine

March 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...